This study is in progress, not accepting new patients
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Summary
- Eligibility
- for people ages 18-80 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Thomas Dewland
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Thomas Dewland
Dr. Dewland is a cardiac electrophysiologist with expertise in treating all aspects of heart rhythm disorders. He performs catheter ablation procedures for supraventricular tachycardia, atrial flutter, atrial fibrillation, premature ventricular contractions, and ventricular tachycardia.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AtriCure, Inc.
- Links
- aMAZE Trial website
- ID
- NCT02513797
- Study Type
- Interventional
- Participants
- Expecting 600 study participants
- Last Updated